Sign Up to like & get
recommendations!
0
Published in 2025 at "British journal of haematology"
DOI: 10.1111/bjh.70180
Abstract: Despite intensive treatment, patients with relapsed or refractory acute myeloid leukaemia (AML) have a dismal prognosis. A cornerstone therapy for relapsed/refractory AML is a combination of fludarabine (F‐ara‐A) and cytarabine (ara‐C), so‐called FLA. As the…
read more here.
Keywords:
myeloid leukaemia;
hydroxyurea hydroxycarbamide;
acute myeloid;
cytarabine ... See more keywords